Literature DB >> 6387607

The onset of breathing at birth stimulates pulmonary vascular prostacyclin synthesis.

C W Leffler, J R Hessler, R S Green.   

Abstract

The purpose of the present study was to determine if pulmonary prostacyclin synthesis was stimulated by spontaneous onset of breathing by unanesthetized fetuses at birth. Cannulae were implanted and flow cuffs placed in fetal lambs and goats (0.93 term). Fetuses were delivered by cesarean section at 0.95 term and began breathing spontaneously. Prostacyclin in blood was determined by radioimmunoassay of its hydrolysis product, 6-ketoprostaglandin F1 alpha using methods that produced the same values in duplicate samples as did gas chromatography with electron capture detection. Fetal pulmonary prostacyclin production (left lung) [(left pulmonary venous concentration-pulmonary arterial concentration) X left pulmonary blood flow] was undetectable [-1.7 +/- 1.0 (SEM) ng PGI2 X kg-1 X min-1] and fetal pulmonary vascular resistance (left lung) high (5.1 +/- 0.9 mm Hg X kg X min X ml-1). Pulmonary prostacyclin production increased to 30.1 +/- 12.3 ngPGI2 X kg-1 X min-1 and pulmonary vascular resistance declined to 0.5 +/- 0.1 mm Hg X kg X min X ml-1 15 min after birth. Pulmonary vascular resistance remained low even though pulmonary prostacyclin production fell 2-5 h after birth. These results, coupled with earlier studies using indomethacin to inhibit prostaglandin synthesis, support the hypothesis that pulmonary prostacyclin synthesis participates in the decline of pulmonary vascular resistance that accompanies the onset of ventilation at birth, but may be less important in maintenance of low pulmonary vascular resistance once reduced pulmonary vascular tone has been established.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387607     DOI: 10.1203/00006450-198410000-00006

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  23 in total

1.  Fatal persistent pulmonary hypertension presenting late in the neonatal period.

Authors:  J Raine; A A Hislop; A N Redington; S G Haworth; E A Shinebourne
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

2.  Pulmonary hemodynamic responses to in utero ventilation in very immature fetal sheep.

Authors:  Beth J Allison; Kelly J Crossley; Sharon J Flecknoe; Colin J Morley; Graeme R Polglase; Stuart B Hooper
Journal:  Respir Res       Date:  2010-08-19

3.  Postnatal circulatory adaptation in healthy term and preterm neonates.

Authors:  N J Evans; L N Archer
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

4.  Ventilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs.

Authors:  S M Black; M J Johengen; Z D Ma; J Bristow; S J Soifer
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 5.  Unique aspects of the developing lung circulation: structural development and regulation of vasomotor tone.

Authors:  Yuangsheng Gao; David N Cornfield; Kurt R Stenmark; Bernard Thébaud; Steven H Abman; J Usha Raj
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

Review 6.  Changes of the cardiovascular system during the perinatal period.

Authors:  H Stopfkuchen
Journal:  Eur J Pediatr       Date:  1987-11       Impact factor: 3.183

Review 7.  Neonatal pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

8.  Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.

Authors:  D D Ivy; J P Kinsella; S H Abman
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 9.  Non-narcotic analgesics. Use in pregnancy and fetal and perinatal effects.

Authors:  M A Heymann
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Oxygen modulates prostacyclin synthesis in ovine fetal pulmonary arteries by an effect on cyclooxygenase.

Authors:  P W Shaul; W B Campbell; M A Farrar; R R Magness
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.